Cargando…
The Effect of Achieving Serologic Remission on Subsequent Risk of Relapse, End-Stage Renal Disease, and Mortality in ANCA-Associated Vasculitis: A Target Trial Emulation Study
OBJECTIVE: To evaluate the effect of achieving a negative post-induction ANCA assay on the risk of relapse, end stage renal disease (ESRD), and death in ANCA-associated vasculitis (AAV). METHODS: We emulated a target trial using observational data from the Mass General Brigham AAV cohort comparing p...
Autores principales: | McDermott, Gregory C., Fu, Xiaoqing, Cook, Claire, Ahola, Catherine, Doliner, Brett, Hanberg, Jennifer, Stone, John H., Choi, Hyon K., Zhang, Yuqing, Wallace, Zachary S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474699/ https://www.ncbi.nlm.nih.gov/pubmed/35697489 http://dx.doi.org/10.1136/annrheumdis-2022-222439 |
Ejemplares similares
-
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017) -
Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019) -
Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis
por: Knütter, Ilka, et al.
Publicado: (2012) -
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020) -
EP28 A case of ANCA vasculitis presenting with Sjögren’s serology
por: Ayub, Shazeen, et al.
Publicado: (2020)